William John Scheessele

Chief Commercial Officer, Humacyte, Inc.

Companies

Humacyte, Inc.Chief Commercial Officer Aug 27, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Humacyte, Inc. HUMA22,018 shares²$9.7K at $0.44Apr 14, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 14, 2025Bought 6,493 shares at $1.54 of Humacyte, Inc.²
Dec 13, 2022Bought 5,000 shares at $3.09 of Humacyte, Inc.³
May 24, 2022Bought 10,525 shares at $4.72 of Humacyte, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHumacyte, Inc., Chief Commercial Officer
2
SEC EDGARHumacyte, Inc. shares after the filing of Apr 14, 2025
3
SEC EDGARForm 4 filed Dec 15, 2022
4
SEC EDGARForm 4 filed May 25, 2022